血管化复合性全移植中耐受性诱导的当前状态
Caitlin M Blades1, Christene A Huang, David W Mathes
1Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Colorado Denver/Anschutz Medical Campus, Aurora, Colorado, USA.
Current opinion in organ transplantation
|October 18, 2024
概括
诱导免疫耐受性是血管化复合性全移植 (VCA) 中长期生存的关键. 最近的研究表明,使用捐赠者T细胞,临床上可用的试剂和非骨髓衰变方法有前途,为减少免疫抑制铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
- 再生医学是一种再生医学.
背景情况:
- 血管化复合性全移植 (VCA) 由于免疫排斥而面临重大障碍,类似于固体器官移植.
- 尽量减少免疫抑制和克服急性/慢性排斥对于成功的长期VCA异种移植生存至关重要.
研究的目的:
- 审查最近在诱导对VCA的免疫耐受性方面的进展.
- 通过临床视角讨论临床前研究的关键发现.
主要方法:
- 关于VCA耐受性诱导的近期临床前研究的审查.
- 分析与来自捐赠者的T细胞,试剂的可用性和非骨髓缩方法相关的发现.
- 研究环境因素,如NB-UVB光用于免疫调节.
主要成果:
- 临床前研究表明,供体T细胞与VCA耐受性之间存在联系.
- 通过使用临床可用的试剂和非骨髓衰变方法,成功诱导耐受性.
- 环境因素,包括NB-UVB光,显示出VCA中免疫调节的潜力.
结论:
- 尽量减少免疫抑制对于扩大VCA应用至关重要.
- 耐受性诱导协议需要低毒性,最小侵入性疗法和短期免疫抑制.
- 最近的研究里程碑为VCA的临床转化提供了新的免疫调节策略.
相关概念视频
01:24Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
01:40Cell-mediated Immune Responses
67.4K
Overview
67.4K